{
    "clinical_study": {
        "@rank": "110865", 
        "acronym": "UVENTA", 
        "arm_group": {
            "arm_group_label": "cSEMS", 
            "arm_group_type": "Experimental", 
            "description": "Patients with malignant ureteral obstruction have cSEMS(Covered self-expandable dual-layered metal stent) implant"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate Efficacy and Safety of a covered self-expandable\n      dual-layered metallic mesh stent (UVENTA) in ureteral obstruction."
        }, 
        "brief_title": "Efficacy and Safety of a Covered Self-expandable Dual-layered Metallic Mesh Stent (UVENTA) in Ureteral Obstruction", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Ureteral Obstruction", 
        "condition_browse": {
            "mesh_term": "Ureteral Obstruction"
        }, 
        "detailed_description": {
            "textblock": "Prospective, Multi-center, open label, single arm Study\n\n        1. Treatment\n\n           - Covered self-expandable dual-layered metallic mesh Stents(cSEMS) are implanted in\n           patents with malignant ureteral obstruction\n\n        2. Follow up\n\n             -  Assessments including X-ray(KUB), are done 3, 6, 12, 18 and 24 months after the\n                procedure.\n\n             -  Diuretic RI scan (DTPA, MAG-3) 3, 6, 12 months after the procedure\n\n             -  Imaging such as IVP(Intravenous Pyelogram), ultrasonogram, CT(Computed Tomogram)\n                are performed at 6 and 12 months."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Patients who voluntarily agree to participation and submitted a written informed\n             consent for this study, and 20~80 years\n\n          2. One out of following cases below apply to Patients who have malignant ureteral\n             obstruction or have benign ureteral obstruction without improvement after previous\n             treatment\n\n               -  Patients who doesn't want to have regular replacement of plastic stent\n\n               -  Patients who has no improvement of obstruction after plastic stent implant\n\n               -  Patients who want other Urinary diversion because of stimulatory sign or pain\n                  due to plastic stent\n\n          3. Patients with no previous ureteral metal stenting procedure experience.\n\n          4. Patients with more than 6 months of life expectancy\n\n          5. Patients understanding the objective of the study and who are willing to sign a\n             consent\n\n        Exclusion Criteria:\n\n          1. Patients with Urothelial Carcinoma\n\n          2. Patients with bladder invasion of malignant tumor\n\n          3. Patients with bladder dysfunction or obstruction of lower urinary tract\n\n          4. one or more times Recurrent Urinary stone in the last 3 years\n\n          5. 2 or more times upper urinary tract infection without upper urinary tract obstruction\n\n          6. Karnofsky scores < 60\n\n          7. Patients with Bacteriuria\n\n          8. Inadequate Patient to participate in the study as judged by the investigator"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "92", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01788865", 
            "org_study_id": "URT-001"
        }, 
        "intervention": {
            "arm_group_label": "cSEMS", 
            "intervention_name": "cSEMS(Covered self-expandable dual-layered metal stent) implant", 
            "intervention_type": "Device", 
            "other_name": "UVENTA\u2122 Ureteral Stent, Taewoong medical"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "covered Metal stent", 
            "ureteral obstruction"
        ], 
        "lastchanged_date": "February 7, 2013", 
        "location": [
            {
                "contact": {
                    "email": "hkpark@amc.seoul.kr", 
                    "last_name": "Hyeong keoun Park, M.D. Ph.D,", 
                    "phone": "+82-2-3010-3737"
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Asan Medical Center"
                }, 
                "investigator": {
                    "last_name": "Hyeongkeun Park, M.D. Ph.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "deokhyun.han@gmail.com", 
                    "last_name": "Deokhyun Han, M.D.", 
                    "phone": "+82-10-9933-5125"
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Samsung Medical Center"
                }, 
                "investigator": {
                    "last_name": "Deokhyun Han, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "1", 
        "official_title": "Efficacy and Safety of a Covered Self-expandable Dual-layered Metallic Mesh Stent (UVENTA\u2122) in Ureteral Obstruction: Prospective, Multi-center, Open Label Study", 
        "overall_contact": {
            "email": "deokhyun.han@gmail.com", 
            "last_name": "Deok Hyun Han, M.D.", 
            "phone": "82-2-3410-6431"
        }, 
        "overall_official": [
            {
                "affiliation": "Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine", 
                "last_name": "Deok Hyun Han, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Department of Urology, Asan Medical Center", 
                "last_name": "Hyeong keun Park, M.D. Ph.D.", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "South Korea: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Rate of Ureter units maintaining patency without interventions after technical success of the primary procedure(Diuretic RI scan: T\u00bd < 20 min)", 
            "measure": "Primary patency rate", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01788865"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Samsung Medical Center", 
            "investigator_full_name": "HAN, DEOK HYUN", 
            "investigator_title": "HAN, DEOK HYUN", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Rate of technical success(each Ureter) resolving the stenosis and passing the contrast medium from the kidney to urinary bladder", 
                "measure": "Technical success rate", 
                "safety_issue": "No", 
                "time_frame": "1week, 1 month"
            }, 
            {
                "description": "Rate of Ureter units maintaining patency without interventions aside from re-stenting(investigational device) after technical success of the primary procedure(Diuretic RI scan: T\u00bd < 20 min)", 
                "measure": "Final patency rate", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "description": "Rate of total Adverse Events and Adverse Events relevant to Investigational Device", 
                "measure": "Adverse Event", 
                "safety_issue": "Yes", 
                "time_frame": "1week, 1, 3, 6, 9, 12 months"
            }, 
            {
                "description": "Age, Sex, type of tumor(benign/malignant), length of stenosis, location of stenosis, UVJ cross, balloon catheterization, etc.", 
                "measure": "Predictive Risk Factors for Primary patency rate", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "description": "difference of the primary patency between the group of Distal stent located in urinary bladder and ureter", 
                "measure": "the primary patency rate among different location of distal stent", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "description": "Comparative analysis of USSQ : before procedure and after procedure", 
                "measure": "Ureteral stent symptom questionnaire(USSQ)", 
                "safety_issue": "No", 
                "time_frame": "1, 3, 6, 9, 12 months"
            }
        ], 
        "source": "Samsung Medical Center", 
        "sponsors": {
            "collaborator": {
                "agency": "Taewoong Medical Co., Ltd.", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Samsung Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2012", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2013"
    }
}